Find a TenderAwarded without competitionContract details notice

Published 21 May 2025, 10:47 BST

Official UK procurement notice

ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL

Official notice

Authority: Belfast Health and Social Care Trust (Central government)

Direct award

Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)

Awarded value£750,000published award · exc. VAT

Awarded 21 May 2025no call for competition

Awarded to Alloga UK

What is being bought

Published requirement description

Procurement of ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: Northern Ireland

33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record

Procedure method: Direct award
Legal basis: UKPGA · 2023/54 Procurement Act 2023
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 21 May 2025, 10:47 BST
Last source update: 6 Jun 2025, 14:12 BST
Authority reference: DACPM2025-26
FTS notice number: 2025/S 000-030614
Latest notice: Contract details notice (UK7)
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-051a06 Find a Tender

Why no open competition: Additional Repeat Extension Partial Replacement
Published justification: These essential medicines are required for continuity of patient care. These medicines are available only from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

How it was run

Official notice

Submission deadline: —

Timeline

2 Jun 2025 → 6 Jun 2025 · 2 dates

Standstill ends
2 Jun 2025, 23:59 BST
Notice published
6 Jun 2025, 14:12 BST

Notice history

4 events · 3 releases on Find a Tender · since 21 May 2025

Transparency notice published
21 May 2025, 10:47 BST
UK5
Contract award notice published
21 May 2025, 10:52 BST
UK6
Contract details notice published
6 Jun 2025, 14:12 BST
UK7
Contract signature expected
16 Jun 2025, 23:59 BST
scheduled

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £750,0001 award exc. VAT

Contracts signed 1latest 3 Jun 2025

Awarded to	Value	Date	Status
Alloga UK17 Jun 2025 – 30 Jun 2027	£750,000	21 May 2025	Awarded

Contracts

ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL, · Alloga UK
Signed
3 Jun 2025
Value
£750,000
Period
3 Jun 2025 – 30 Jun 2027
Status
active
No agreed KPIs: Contract value is below the relevant threshold for Key Performance indicators

Contracting authority & participating public bodies

Belfast Health & Social Care Trust

Contracting authorityPublic authority - central governmentNorthern Irish devolved regulations apply GB-PPON: PLQJ-5727-JCLR Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BAContact email

Bidders & participating suppliers

1 commercial party on the notice

ALLOGA UK LIMITEDAwarded supplierGB-COH: 03169255GB-PPON: PBTH-6754-GVPN Amber Park, Alfreton, East Midlands, DE55 2FHContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender6 Jun 2025, 14:12 BST
Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender21 May 2025, 10:52 BST
Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender21 May 2025, 10:47 BST